Astera Labs Common Stock's Revenue
- Astera Labs Common Stock's annual revenue was $852.53 M in fiscal year 2025. The annual revenue increased $456.24 M from $396.29 M (in 2024) to $852.53 M (in 2025), representing a 115.13% year-over-year growth.
- Astera Labs Common Stock's quarterly revenue was $270.58 M in the quarter ending Dec 2025. The quarterly revenue increased $129.49 M from $141.10 M (in Q4: Sept 2024) to $270.58 M (in Q4: Sept 2025), representing a 91.77% year-over-year growth.
- The highest annual revenue for Astera Labs Common Stock was $852.53 M in fiscal year 2025.
- The lowest annual revenue was $115.79 M in fiscal year 2023.
- The average revenue was $454.87 M.
- Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2016 - 2025):
Learn more about Astera Labs Common Stock's Revenue by Segment and Revenue by Region.
Check out competitors to Astera Labs Common Stock in a side-by-side comparison.
Explore additional financial metrics for Astera Labs Common Stock.
Definition of Revenue :
Astera Labs Common Stock's Revenue Trend
| 2022 | 79872000.00 |
|---|---|
| 2023 | 115794000.00 |
| 2024 | 396290000.00 |
| 2025 | 852525000.00 |
| Mar 2022 | 15018000.00 |
|---|---|
| Jun 2022 | 21396000.00 |
| Sep 2022 | 23103000.00 |
| Dec 2022 | 20355000.00 |
| Mar 2023 | 17664000.00 |
| Jun 2023 | 10688000.00 |
| Sep 2023 | 36928000.00 |
| Dec 2023 | 50514000.00 |
| Mar 2024 | 65258000.00 |
| Jun 2024 | 76850000.00 |
| Sep 2024 | 113086000.00 |
| Dec 2024 | 141096000.00 |
| Mar 2025 | 159442000.00 |
| Jun 2025 | 191925000.00 |
| Sep 2025 | 230575000.00 |
| Dec 2025 | 270583000.00 |
2025
Astera Labs Common Stock's annual revenue was $852.53 M in fiscal year 2025.
Astera Labs Common Stock's quarterly revenue was $159.44 M(Q1: Mar 2025), $191.93 M(Q2: Jun 2025), $230.58 M(Q3: Sep 2025), $270.58 M(Q4: Dec 2025) in fiscal year 2025.
2024
Astera Labs Common Stock's annual revenue was $396.29 M in fiscal year 2024.
Astera Labs Common Stock's quarterly revenue was $65.26 M(Q1: Mar 2024), $76.85 M(Q2: Jun 2024), $113.09 M(Q3: Sep 2024), $141.10 M(Q4: Dec 2024) in fiscal year 2024.
2023
Astera Labs Common Stock's annual revenue was $115.79 M in fiscal year 2023.
Astera Labs Common Stock's quarterly revenue was $17.66 M(Q1: Mar 2023), $10.69 M(Q2: Jun 2023), $36.93 M(Q3: Sep 2023), $50.51 M(Q4: Dec 2023) in fiscal year 2023.
2022
Astera Labs Common Stock's annual revenue was $79.87 M in fiscal year 2022.
Astera Labs Common Stock's quarterly revenue was $15.02 M(Q1: Mar 2022), $21.40 M(Q2: Jun 2022), $23.10 M(Q3: Sep 2022), $20.36 M(Q4: Dec 2022) in fiscal year 2022.
Astera Labs Common Stock's Revenue (Year-over-Year Change)
| 2022 | 0 |
|---|---|
| 2023 | +44.97 |
| 2024 | +242.24 |
| 2025 | +115.13 |
| Q1: Mar 22 | 0 |
|---|---|
| Q2: Jun 22 | 0 |
| Q3: Sep 22 | 0 |
| Q4: Dec 22 | 0 |
| Q1: Mar 23 | 17.62 |
| Q2: Jun 23 | -50.05 |
| Q3: Sep 23 | 59.84 |
| Q4: Dec 23 | 148.17 |
| Q1: Mar 24 | 269.44 |
| Q2: Jun 24 | 619.03 |
| Q3: Sep 24 | 206.23 |
| Q4: Dec 24 | 179.32 |
| Q1: Mar 25 | 144.33 |
| Q2: Jun 25 | 149.74 |
| Q3: Sep 25 | 103.89 |
| Q4: Dec 25 | 91.77 |
2025
Astera Labs Common Stock’s annual revenue increased +115.13% during fiscal year 2025 compared to 2024. It represents a growth of $456.24 M from $396.29 M (in 2024) to $852.53 M (in 2025).
2024
Astera Labs Common Stock’s annual revenue increased +242.24% during fiscal year 2024 compared to 2023. It represents a growth of $280.50 M from $115.79 M (in 2023) to $396.29 M (in 2024).
2023
Astera Labs Common Stock’s annual revenue increased +44.97% during fiscal year 2023 compared to 2022. It represents a growth of $35.92 M from $79.87 M (in 2022) to $115.79 M (in 2023).
Summary Table (Annual)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| 2025 | $852.53 M | +115.13% |
| 2024 | $396.29 M | +242.24% |
| 2023 | $115.79 M | +44.97% |
Summary Table (Quarterly)
| Period | Revenue | Year-over-Year Change |
|---|---|---|
| Q4: Dec 25 | $270.58 M | 91.77% |
| Q3: Sep 25 | $230.58 M | 103.89% |
| Q2: Jun 25 | $191.93 M | 149.74% |
| Q1: Mar 25 | $159.44 M | 144.33% |
| Q4: Dec 24 | $141.10 M | 179.32% |
| Q3: Sep 24 | $113.09 M | 206.23% |
| Q2: Jun 24 | $76.85 M | 619.03% |
| Q1: Mar 24 | $65.26 M | 269.44% |
| Q4: Dec 23 | $50.51 M | 148.17% |
| Q3: Sep 23 | $36.93 M | 59.84% |
| Q2: Jun 23 | $10.69 M | -50.05% |
| Q1: Mar 23 | $17.66 M | 17.62% |
| Q4: Dec 22 | $20.36 M | - |
| Q3: Sep 22 | $23.10 M | - |
| Q2: Jun 22 | $21.40 M | - |
| Q1: Mar 22 | $15.02 M | - |
